Bioresorbable Polymers Market (By Product: Proteins, Polylactic Acid, Polysaccharides, Polyglycolic Acid, Polycaprolactone; By Application: Orthopedics, Drug delivery, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global bioresorbable polymers market size was valued at USD 1.52 billion in 2023 and is anticipated to reach around USD 5.55 billion by 2033, growing at a CAGR of 13.83% from 2024 to 2033. When utilized in medical applications, such as implants or medication delivery systems, bioresorbable polymers lower the possibility of immunological responses or unpleasant reactions because they are compatible with biological systems.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The U.S. bioresorbable polymers market size was estimated at USD 380 million in 2023 and is predicted to be worth around USD 1,380 million by 2033, at a CAGR of 13.76% from 2024 to 2033.
North America held the largest share of the bioresorbable polymers market in 2023. Due to the rising demand for bioresorbable polymers in a variety of applications, including packaging materials, drug delivery systems, and medical devices, the market for these polymers has been expanding rapidly in North America. These polymers can be used for a variety of purposes because of their benefits, which include biocompatibility, biodegradability, and flexibility. Innovative medical devices with improved biocompatibility and a lower risk of consequences are in greater demand due to the aging population and the rise in chronic diseases. The bioresorbable polymers market is expanding as a result of ongoing R&D efforts to create sophisticated, improved-property bioresorbable polymers. A growing number of people are interested in bioresorbable polymers as sustainable alternatives to conventional plastics due to rising environmental awareness and worries about plastic pollution.
Asia Pacific is emerging as the fastest-growing region in the global bioresorbable polymers market. The region's market has grown significantly in recent years due to a number of factors, including rising healthcare costs, growing public awareness of sustainable and biodegradable materials, and expanding demand for cutting-edge medical technologies. Key participants in this market include China, Japan, India, and South Korea because of their sizable patient populations and strong healthcare infrastructures. Further driving up demand for bioresorbable polymers used in implants and medical equipment is the region's recent boom in medical tourism. The need for bioresorbable polymers is growing in the area due to the rising incidence of chronic illnesses and technological developments in medicine.
The Asia Pacific bioresorbable polymers market size was calculated at USD 400 million in 2023 and is expected to cross around USD 1,470 million by 2033, rising at a CAGR of 13.90% from 2024 to 2033.
Year | Market Size (USD Million) |
2023 | 400 |
2024 | 450 |
2025 | 510 |
2026 | 580 |
2027 | 660 |
2028 | 750 |
2029 | 860 |
2030 | 980 |
2031 | 1,110 |
2032 | 1,270 |
2033 | 1,470 |
The bioresorbable polymers market is primarily driven by their wide applicability in medical settings, including tissue engineering, orthopedic implants, drug delivery systems, and sutures. These polymers are very attractive in the medical field since they can break down within the body into non-toxic metabolites, removing the need for removal operations. Bioresorbable polymers are finding more and more uses in eco-friendly packaging solutions outside of the medical field.
Advanced bioresorbable polymers with enhanced qualities like mechanical strength, degradation rate control, and medication compatibility have been developed as a result of ongoing research and development activities. The bioresorbable polymers market is anticipated to keep growing due to technological developments, an increase in applications, and growing consumer awareness of environmental sustainability. The market for biodegradable and compostable packaging materials is expanding as a result of legislation designed to reduce plastic waste and growing environmental concerns.
Despite promising development potential, obstacles, including elevated production costs and restricted scalability of production processes, persist. Ongoing initiatives to address these issues, together with rising R&D spending, offer market participants extremely profitable prospects. The bioresorbable polymers market is expanding significantly worldwide, but it is primarily growing in North America and Europe because of their developed healthcare systems, robust research programs, and supportive policies that encourage the use of biodegradable materials.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 13.83% |
Global Market Size in 2023 | USD 1.52 Billion |
Global Market Size in 2024 | USD 1.73 Billion |
Global Market Size by 2033 | USD 5.55 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product, and By Application |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Research and development
Within the larger subject of biomaterials science, bioresorbable polymer research and development is a fascinating area. These polymers—also referred to as bioabsorbable or biodegradable polymers—have attracted a lot of interest because of their potential uses in a variety of industries, such as tissue engineering, regenerative medicine, drug delivery systems, and medical devices. In order to enhance a bioresorbable polymer's mechanical strength, degradation kinetics, and biocompatibility, researchers are always creating new ones or changing ones that already exist. Bioresorbable polymers are being functionalized to give them certain qualities or functions, like controlled medication release, cell adhesion, or antibacterial action. As the bioresorbable polymers market grows, so does the need to meet regulatory criteria and guarantee the efficacy and safety of the products.
Restraint: Degradation rate variability
One factor that significantly affects the bioresorbable polymers market in a variety of industries, including packaging, medicine, and pharmaceuticals, is the market's variability in degradation rates. Biodegradable or bioresorbable polymers are substances that, when broken down over time, produce harmless byproducts that the body can either absorb or eliminate. The rate at which bioresorbable polymers degrade can be affected by the processing techniques employed to create those products. The polymer's crystallinity, shape, and degradation kinetics can all be impacted by processing variables like temperature, pressure, and solvent choice. While stabilizers and antioxidants can prolong the polymer's shelf life or slow down breakdown, fillers, and reinforcing agents can change the kinetics of degradation by altering the migration of enzymes and water molecules into the polymer matrix.
Opportunity: Tissue engineering and regenerative medicine
The goal of the exciting fields of tissue engineering and regenerative medicine is to replace damaged human organs and tissues with functioning ones. In these domains, the bioresorbable polymers market is important because it offers matrices or scaffolds for the development of cells and tissues. Because of the way these polymers break down over time, the scaffold will eventually be replaced by freshly created tissue. Global population aging is predicted to increase demand for regenerative medicine and tissue replacements, which will propel the market for bioresorbable polymers in tissue engineering. The exact creation of complex tissue scaffolds utilizing bioresorbable polymers has been made possible by developments in 3D printing, microfabrication, and biomaterial processing. This has expanded the use of these scaffolds in regenerative medicine.
The polylactic acid segment held the largest share of the bioresorbable polymers market in 2023 and is expected to maintain its dominance during the forecast period. In fact, a big contender in the market for bioresorbable polymers is polylactic acid (PLA). It is a biodegradable polyester made from sugarcane or corn starch, two renewable resources. PLA has drawn interest because of its mechanical strength, thermal stability, and biocompatibility, which make it ideal for a range of uses in the packaging, textile, and medical sectors. PLA is frequently utilized in the medical industry for scaffolds for tissue engineering, orthopedic implants, medication delivery systems, and sutures. Because it lowers the risk of infection and does away with the necessity for removal operations, its biodegradability and compatibility with the human body make it an appealing option for these kinds of applications.
The polyglycolic acid segment is expected to grow rapidly during the forecast period. In fact, PGA is a major player in the market for bioresorbable polymers. Bioresorbable polymers, also called biodegradable polymers, are substances that, after serving their original purpose, break down within the body into non-toxic byproducts, obviating the need for surgical removal. Because of its mechanical strength, biocompatibility, and capacity to break down into non-toxic components like glycolic acid, PGA is especially important. Applications for PGA include scaffolds for tissue engineering, medication delivery devices, and surgical sutures. Its mechanical strength is retained during the crucial healing phase, after which it breaks down spontaneously and leaves no trace. This is why it is so popular. Because of this feature, PGA is a desirable choice for a range of medical applications where momentary support is required.
The orthopedics segment held the dominant share of the bioresorbable polymers market in 2023. The development of bioresorbable polymers in the orthopedics field has resulted in notable breakthroughs in recent years. These polymers' biodegradability and body compatibility make them a possible substitute for conventional materials used in orthopedic implants, such as metals. Because bioresorbable polymers break down naturally over time in the body, they can be removed surgically once the healing process is over. This characteristic lowers the possibility of persistent implant-related problems in the long run. Compared to metals, bioresorbable polymers provide more design and production freedom. This makes it possible to create implants that are specifically suited to the anatomy and requirements of each patient.
The drug delivery segment is expected to grow at the fastest CAGR during the forecast period. Within the pharmaceutical and biomedical industries, drug delivery within bioresorbable polymers is an exciting area of research and development. Biodegradable or bioresorbable polymers are substances that break down over time into harmless byproducts that the body may process or excrete. Bioresorbable polymers can be designed to target particular human tissues or organs, reducing the likelihood of systemic side effects and increasing the medication's therapeutic effectiveness. Anti-restenosis medications are delivered directly to the site of arterial injury using drug-eluting stents composed of bioresorbable polymers, which lowers the chance of the blood artery narrowing again.
Segment Covered in the Report
By Product
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioresorbable Polymers Market
5.1. COVID-19 Landscape: Bioresorbable Polymers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioresorbable Polymers Market, By Product
8.1. Bioresorbable Polymers Market Revenue and Volume, by Product, 2024-2033
8.1.1. Proteins
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Polylactic Acid
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Polysaccharides
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Polyglycolic Acid
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Polycaprolactone
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Bioresorbable Polymers Market, By Application
9.1. Bioresorbable Polymers Market Revenue and Volume, by Application, 2024-2033
9.1.1. Orthopedics
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Drug delivery
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Bioresorbable Polymers Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.5.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
Chapter 11. Company Profiles
11.1. Corbion N.V
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Evonik Industries AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Foster Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. KLS Martin Group
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. DSM Biomedical
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Ashland Global Holdings Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client